UPDATE: BofA Securities Upgrades Mirati Therapeutics (MRTX) to Neutral on Valuation
Tweet Send to a Friend
(Updated - February 1, 2022 8:45 AM EST)
BofA Securities analyst Jason Gerberry upgraded Mirati Therapeutics (NASDAQ: MRTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Gerberry upgraded Mirati Therapeutics (NASDAQ: MRTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
